Carregant...
Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network
Advanced melanoma has been traditionally unresponsive to standard chemotherapy agents and used to have a dismal prognosis. Genetically targeted small-molecule inhibitors of the oncogenic BRAF V600 mutation or a downstream signaling partner (MEK mitogen-activated protein kinase) are effective treatme...
Guardat en:
| Publicat a: | Clin Kidney J |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792624/ https://ncbi.nlm.nih.gov/pubmed/26985376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfv149 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|